The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include details about how Medicare Part B drugs and renegotiation processes will be ...
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) published the final guidance for the third cycle of the Medicare Drug Price Negotiation Program, initial price applicability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results